Why us?
Our mission: To accelerate cell and gene therapy development in Thailand by providing every scientist, clinician, and manufacturer with the right reagent, at the right grade, at the right time — backed by local expertise, regulatory knowledge, and 35 years of trust. Thai Can Biotech Co., Ltd. was founded in August 1991 under the Thai-Canadian Biotechnology Linkage Program (Phase II). Over 35 years, TCB has grown into Thailand's leading importer and distributor of high-quality life science and clinical products, serving universities, hospitals, CDMOs, government research institutes, and private biopharma companies. CGT Division — Thailand's One-Stop Shop for Cell & Gene Therapy In 2026, TCB formally launched its dedicated Cell & Gene Therapy (CGT) Division — the first end-to-end CGT ancillary materials distributor in Thailand. The CGT Division covers every stage of the cell therapy manufacturing workflow across nine supplier partnerships: Bio-Techne/R&D Systems, Akron Bio, Wilson Wolf/G-Rex via ScaleReady™, Lonza TheraPEAK®, BioLife Solutions, STEMCELL Technologies, Terumo BCT, PL BioScience, and Charles River/Lonza LAL. TCB also operates an ISO/IEC 17025:2017-accredited Bacterial Endotoxin Testing laboratory. Our validated cold chain (2-8°C, -20°C, and -80°C) meets GMP-grade biological product handling requirements, including cell therapy ancillary materials.
know us better
เราให้มากกว่าการบริการ
About Us
Our mission: To accelerate cell and gene therapy development in Thailand by providing every scientist, clinician, and manufacturer with the right reagent, at the right grade, at the right time — backed by local expertise, regulatory knowledge, and 35 years of trust. Thai Can Biotech Co., Ltd. was founded in August 1991 under the Thai-Canadian Biotechnology Linkage Program (Phase II). Over 35 years, TCB has grown into Thailand's leading importer and distributor of high-quality life science and clinical products, serving universities, hospitals, CDMOs, government research institutes, and private biopharma companies. CGT Division — Thailand's One-Stop Shop for Cell & Gene Therapy In 2026, TCB formally launched its dedicated Cell & Gene Therapy (CGT) Division — the first end-to-end CGT ancillary materials distributor in Thailand. The CGT Division covers every stage of the cell therapy manufacturing workflow across nine supplier partnerships: Bio-Techne/R&D Systems, Akron Bio, Wilson Wolf/G-Rex via ScaleReady™, Lonza TheraPEAK®, BioLife Solutions, STEMCELL Technologies, Terumo BCT, PL BioScience, and Charles River/Lonza LAL. TCB also operates an ISO/IEC 17025:2017-accredited Bacterial Endotoxin Testing laboratory. Our validated cold chain (2-8°C, -20°C, and -80°C) meets GMP-grade biological product handling requirements, including cell therapy ancillary materials.
Products Recommend
The best brands for you need and take advantage of our service to support your implementation
View All